Recent Work
-
Comments to CMS on Transcatheter Tricuspid Valve Replacement (TTVR) and Broader CED Policy Considerations
Schaeffer Center experts provided comments to CMS on issues with how Coverage with Evidence Determination policy is applied.
Categorized in -
A Roadmap for Improving Medicare’s Application of Coverage With Evidence Development
CED has the potential to improve access to technologies, promote innovation, and drive evidence generation. However, CMS, manufacturers, researchers, policy makers, patients, and others must first work together.
Categorized in -
A Strategy for Value-Based Drug Pricing Under the Inflation Reduction Act
To make sure that CMS is getting its money’s worth for today’s drugs, it must ensure that the maximum fair price is aligned to drug value.
Categorized in -
Comments to CMS on the Inflation Reduction Act’s Drug Price Negotiation Program
Over 20 researchers cosigned a comment letter to Centers for Medicaid and Medicare Services providing recommendations for the Medicare Drug Price Negotiation Program
Categorized in -
Addressing Challenges to Alternative Payment Models for New Alzheimer’s Disease Therapies for US Commercial Payers
Developing a blueprint to overcome challenges in implementing new payment models will ensure better access.
Categorized in